Protective Effect of Polysaccharide from <i>Gastrodia elata</i> Blume on Non-alcoholic Fatty Liver Induced by High Fat Diet

FAN Rong; MA Guohua; YU Shanshan

doi:10.13386/j.issn1002-0306.2021040193

Volume 43 Issue 1

Dec. 2021

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2022 > 43(1): 381-391. > DOI: 10.13386/j.issn1002-0306.2021040193

FAN Rong, MA Guohua, YU Shanshan. Protective Effect of Polysaccharide from Gastrodia elata Blume on Non-alcoholic Fatty Liver Induced by High Fat Diet[J]. Science and Technology of Food Industry, 2022, 43(1): 381−391. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021040193.

Citation:

PDF (2964 KB)

Protective Effect of Polysaccharide from Gastrodia elata Blume on Non-alcoholic Fatty Liver Induced by High Fat Diet

The Second Affiliated Hospital of Liaoning University of Traditinal Chinese Medicine, Shenyang 110032, China

More Information

Received Date: April 25, 2021
Available Online: November 05, 2021

Graphical Abstract

Abstract

Abstract

Objective: To investigate the protective and delayed effects of Gastrodia elata polysaccharide on non-alcoholic fatty liver (NAFLD) and its molecular mechanism. Methods:60 ICR mice were randomly divided into normal group, model group and Gastrodia elata polysaccharide group (50, 100 and 200 mg/kg). Except the normal group, the other groups were given high-fat diet to induce NAFLD model. At the same time, the corresponding drugs were given once a day for 10 weeks. At 30 min after the last administration, the body weight and organ index of mice were recorded, the pathological changes of liver tissue were evaluated by histopathology. At the same time, the activity of serum aspartate amino transferase (AST) and alanine amino transferase (ALT) were measured, and the related signal transduction pathways were examined including oxidative stress injury and lipid metabolism. Results:Compared with the model group, the activity of AST and ALT in serum were significantly decreased (P<0.05), and the pathological symptoms of fatty liver tissue was alleviated, and the level of genes expression related to lipid accumulation were regulated to improve lipid metabolism (P<0.05); In addition, Gastrodia elata polysaccharide also improved oxidative stress injury by upregulating Nrf2/GPX signaling pathway (P<0.05), inhibited the expression of NF-κB, TNF-α, IL-1β, iNOS and COX-2 proteins related to inflammatory response (P<0.05), and inhibited the expression of Bax and upregulated Bcl-2 proteins (P<0.05). Conclusion: Gastrodia elata Blume polysaccharide (GBP) can improve the liver function of NAFLD model mice, regulate the level of lipid metabolism and reduce the accumulation of fat, alleviate the oxidative stress injury of liver and inhibit inflammation to protect and delay NAFLD symptoms caused by high fat diet.

FullText(HTML)

References (55)

References

[1]	RECTOR R S, THYFAULT J P, WEI Y, et al. Non-alcoholic fatty liver disease and the metabolic syndrome: An update[J]. World J Gastroenterol,2008,14(2):185−192. doi: 10.3748/wjg.14.185
[2]	BROWNING J D, HORTON J D. Molecular mediators of hepatic steatosis and liver injury[J]. The Journal of Clinical Investigation,2004,114(2):147−152. doi: 10.1172/JCI200422422
[3]	宫海艳, 姜莉. 慢性阻塞性肺疾病合并肺间质纤维化的研究进展[J]. 国际呼吸杂志,2012,32(14):1098−1104. [ GONG H Y, JIANG L. Research progress of chronic obstructive pulmonary disease with pulmonary fibrosis[J]. International Respiratory Journal,2012,32(14):1098−1104. doi: 10.3760/cma.j.issn.1673-436X.2012.014.015
[4]	张声生, 李乾构, 李军祥. 非酒精性脂肪性肝病中医诊疗共识意见[J]. 北京中医药,2011,30(2):83−86. [ZHANG S S, LI Q G, LI J X. Consensus opinions on diagnosis and treatment of non-alcoholic fatty liver disease in traditional Chinese medicine[J]. Beijing Traditional Chinese Medicine,2011,30(2):83−86.
[5]	范建高. 非酒精性脂肪肝的临床流行病学研究[J]. 中华消化杂志,2002,22(2):106−107. [FAN J G. Clinical epidemiological study of non-alcoholic fatty liver[J]. Chinese Journal of Digestion,2002,22(2):106−107. doi: 10.3760/j.issn:0254-1432.2002.02.012
[6]	ANDRONESCU C, PURCAREA M R, BABES P A. Nonalcoholic fatty liver disease: Epidemiology, pathogenesis and the rapeutic implications[J]. Journal of Medicine and Life,2018,11(1):20−23.
[7]	BEDOGNI G, BELLENTANI S. Fatty liver: How frequent is it and why[J]. Annals of Hepatology,2004,3(2):63−65. doi: 10.1016/S1665-2681(19)32110-6
[8]	DAY C P, JAMES O. Steatohepatitis: A tale of two “hits”[J]. Gastroenterology,1998,114(4):842−845. doi: 10.1016/S0016-5085(98)70599-2
[9]	KOHEI O, HIROFUMI U, SEIICHI M, et al. Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: A review of human studies[J]. Clinical Journal of Gastroenterology,2015,8(1):1−9. doi: 10.1007/s12328-014-0548-5
[10]	REENAM K, FERNANDO B, KEN C, et al. Modulation of insulin resistance in NAFLD[J]. Hepatology,2018,70(2):711−724.
[11]	中国科学院植物研究所. 中国高等植物图鉴: 第五册[M]. 北京: 科学出版社, 2002. Institute of Botany, Chinese Academy of Sciences. An illustrated book of Chinese higher plants: Volume 5 [M]. Beijing: Science Press, 2002.
[12]	国家药典委员会. 中华人民共和国药典(一部)[M]. 北京: 中国医药科技出版社, 2020. National Pharmacopoeia Committee. Pharmacopoeia of the People's Republic of China (Volume I)[M]. Beijing: China Pharmaceutical Science and Technology Press, 2020.
[13]	张金芝, 黄光清, 郑卫红, 等. 天麻素对长春新碱诱导大鼠神经病理性疼痛的抑制作用[J]. 中药药理与临床,2012(6):44−46. [ZHANG J Z, HUANG G Q, ZHENG W H, et al. Inhibitory effect of gastrodin on vincristine induced neuropathic pain in rats[J]. Pharmacology and Clinic of Traditional Chinese Medicine,2012(6):44−46.
[14]	陈小银, 田礼义. 天麻素对戊四氮致痫大鼠海马氨基酸递质的影响[J]. 天津中医药,2009,26(6):476−478. [CHEN X Y, TIAN L Y. Influence of gastrodin on amino acid transmitter in hippocampus of pentylenetetrazole-induced epileptic rats[J]. Tianjin Traditional Chinese Medicine,2009,26(6):476−478.
[15]	许廷生, 陆龙存, 黄子冬. 天麻有效成分的药理作用分析与临床应用研究进展[J]. 中医临床研究,2020,12(21):133−135. [XU T S, LU L C, HUANG Z D. Progress in pharmacological action analysis and clinical application of active components of gastrodia elata[J]. Clinical research of Traditional Chinese Medicine,2020,12(21):133−135.
[16]	王耀, 李光布, 朱启云. 天麻素治疗椎-基底动脉供血不足疗效观察[J]. 中华全科医学,2014,12(2):326−327. [WANG Y, LI G B, ZHU Q Y. Effect of gastrodin on vertebrobasilar insufficiency[J]. Chinese General Medicine,2014,12(2):326−327.
[17]	何珊珊, 李锐, 吴迪, 等. 天麻素对脑缺血再灌注小鼠海马新生神经元的保护作用[J]. 现代生物医学进展,2015,15(32):6241−6244. [HE S S, LI R, WU D, et al. Protective effects of gastrodin on hippocampal newborn neurons in cerebral ischemia-reperfusion[J]. Progress of Modern Biomedicine,2015,15(32):6241−6244.
[18]	赵晓慧, 许燕, 林佶, 徐丹先. 小草坝新鲜天麻中多种金属元素评价分析[J]. 食品安全质量检测学报,2018,9(22):5987−5992. [ZHAO X H, XU Y, LIN J, et al. Evaluation and analysis of many kings of metal elements in Xiaocaoba fresh gastrodia elata in Xiaocaoba[J]. Journal of Food Safety and Quality Inspection,2018,9(22):5987−5992. doi: 10.3969/j.issn.2095-0381.2018.22.032
[19]	吴静澜. 天麻作为保健食品原料药的应用思考[J]. 世界最新医学信息文摘,2017,17(39):103−104. [WU J L. Thoughts on the application of Gastrodia elata as a health food API[J]. World Latest Medical Information Digest,2017,17(39):103−104.
[20]	陈维红, 罗栋. 天麻素、天麻多糖药理作用研究进展[J]. 中国药物评价,2013,30(3):132−141. [CHEN W H, LUO D. Research progress in the pharmacological effects of gastrodin and Gastrodia elata polysaccharides[J]. China Drug Evaluation,2013,30(3):132−141. doi: 10.3969/j.issn.2095-3593.2013.03.002
[21]	李云, 王志伟, 刘大会, 等. 天麻化学成分研究进展[J]. 山东科学,2016,29(4):24−29. [LI Y, WANG Z W, LIU D H, et al. Research progress on the chemical constituents of Gastrodia[J]. Shandong Science,2016,29(4):24−29. doi: 10.3976/j.issn.1002-4026.2016.04.006
[22]	李晶, 苏薇薇, 李沛波, 等. 膜分离技术应用于麦冬多糖纯化工艺的研究[J]. 中医药导报,2017,23(4):51−57. [Li J, Su W W, Li P B, et al. Study on the application of membrane separation technology in the purification process of Ophiopogon japonicus polysaccharide[J]. Guide of Chinese Medicine,2017,23(4):51−57.
[23]	LIU J, MORIA A. Antioxidant and free radical scavenging activi-ties of Gastrodia elata and Uncaria rhynchophylla (Miq) Jacks[J]. Neuropharmacology,1992,31(12):87−98.
[24]	鞠桂春. 天麻及其制剂的药理作用和临床应用研究进展[J]. 中国药业,2008,17(1):64−66. [JU G C. Research progress in the pharmacological effects and clinical application of Gastrodia and its preparations[J]. China Pharmaceuticals,2008,17(1):64−66. doi: 10.3969/j.issn.1006-4931.2008.01.045
[25]	KOMATSU T, KIDO N, SUGIYAMA T, et al. Antiviralactivity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection[J]. Immunopharmacology and Immunotoxicology,2013,35(1):1−7. doi: 10.3109/08923973.2012.710636
[26]	HUANG G B, ZHAO T, MUNA S S, et al. Therapeutic potential of Gastrodia elata Bl. for the treatment of Alzheimer’s disease[J]. Neural Regeneration Research,2013,8(12):1061−1070.
[27]	DOO A R, KIM S N, HAHM D H, et al. Gastrodia elata Bl. alleviates L-DOPA-induced dyskinesia by normalizing FosB and ERK activation in a 6-OHDA-lesioned Parkinson’s disease mouse model[J]. BMC Complementary and Alternative Medicine,2014,14(1):107−114. doi: 10.1186/1472-6882-14-107
[28]	KÜHNEL F, ZENDER L, PAUL Y, et al. NF-κB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis[J]. The Journal of Biological Chemistry,2000,275(5):6421−6427.
[29]	刘涛, 尼玛卓玛, 尼珍. 苯酚-浓硫酸法测定西藏天麻中多糖含量的条件优化[J]. 广东农业科学,2011,38(8):132−134. [LIU T, NIMA Z M, NI Z, et al. Determination of the polysaccharide content of Tibetan Rhizoma Gastrodiae by Phenol-colorimetric concentrated sulfuric acid[J]. Guangdong Agricultural Science,2011,38(8):132−134. doi: 10.3969/j.issn.1004-874X.2011.08.052
[30]	李晓冰, 展俊平, 张月腾, 等. 天麻多糖对环磷酰胺所致免疫功能低下小鼠体液免疫功能的影响[J]. 中国老年学杂志,2016,36(5):1027−1028. [LI X B, ZHAN J P, ZHANG Y T, et al. Effect of polysaccharide from Gastrodia elata B1 on humoral immune function in immunosuppressed mice induced by cyclophosphamide[J]. Chinese Journal of Gerontology,2016,36(5):1027−1028. doi: 10.3969/j.issn.1005-9202.2016.05.002
[31]	HUANG R, ZHAO J, WU F, et al. Effect of electroacupuncture plus polysaccharide of Gastrodia elata Blume on expression of nestin and brain derived neurotrophic factor in the basolateral amygdala of focal cerebral ischemia rats[J]. Acupuncture Research,2016,41(3):230−234.
[32]	JUN N H, XING Y X, WEI L, et al. Ginsenoside Rk1 ameliorates paracetamol-induced hepatotoxicity in mice through inhibition of inflammation, oxidative stress, nitrative stress and apoptosis[J]. Journal of Ginseng Research,2017,43(1):10−19.
[33]	LI W, LIU Y, WANG Z, et al. Platycodin D isolated from the aerial parts of Platycodon grandiflorum protects alcohol-induced liver injury in mice[J]. Food Function,2015,6(5):1418−1427. doi: 10.1039/C5FO00094G
[34]	HAN Y, XU Q, HU J N, et al. Maltol, a food flavoring agent, attenuates acute alcohol-induced oxidative damage in mice[J]. Nutrients,2015,7(1):682−696. doi: 10.3390/nu7010682
[35]	SINGH S, OSNA N A, KHARBANDA K K. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review[J]. World Journal of Gastroenterol,2017,23(36):6549−6570. doi: 10.3748/wjg.v23.i36.6549
[36]	TAKAHASHI Y, SOEJIMA Y, FUKUSATO T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis[J]. World Journal of Gastroenterology,2012,18(19):2300−2308. doi: 10.3748/wjg.v18.i19.2300
[37]	OFOSU A, RAMAI D, REDDY M. Non-alcoholic fatty liver disease: Con-trolling an emerging epidemic, challenges, and future directions[J]. Ann Gastroenterol,2018,31(3):288−295.
[38]	DUMITRASCU D L, NEUMAN M G. Non-alcoholic fatty liver disease: An update on diagnosis[J]. Clujul Medical,2018,91(2):147−150.
[39]	BELLENTANI S, SCAGLIONI F, MARINO M, et al. Epidemiology of non-alcoholic fatty liver disease[J]. Journal of Digestive Diseases,2010,28(1):155−161. doi: 10.1159/000282080
[40]	BRAUD L, BATTAULT S, MEYER G, et al. Antioxidant properties of tea blunt ROS-dependent lipogenesis: Benefificial effffect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat model[J]. The Journal of Nutritional Biochemistry,2017,40:95−104. doi: 10.1016/j.jnutbio.2016.10.012
[41]	SHI J, ZHAO Y, WANG K, et al. Cleavage of GSDMD by inflflammatory caspases determines pyroptotic cell death[J]. Nature,2015,526(7575):660−665. doi: 10.1038/nature15514
[42]	SIRAJ F M, SATHISHKUMAR N, KIM Y J, et al. Ginsenoside F2 possesses anti-obesity activity via binding with PPARγ and inhibiting adipocyte difffferentiation in the 3T3-L1 cell line[J]. Journal of Medicinal Chemistry,2015,30(1):9−14.
[43]	SøNDERGAARD E, JOHANSEN R F, JENSEN M D, et al. Postprandial VLDL-TG metabolism in type 2 diabetes[J]. Metabolism,2017,75:25−35. doi: 10.1016/j.metabol.2017.07.002
[44]	YAN W, ZHANG H, LIU P, et al. Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart[J]. Basic Research in Cardiology,2013,108(3):329−343. doi: 10.1007/s00395-013-0329-1
[45]	LI Y, XU S, MIHAYLOVA M M, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice[J]. Cell Metabolism,2011,13(4):376−388. doi: 10.1016/j.cmet.2011.03.009
[46]	BERLANGA A, GUIU-JURADO E, PORRAS J A, et al. Molecular pathways in non-alcoholic fatty liver disease[J]. Clin Exp Gastroenterol,2014,7:221−239.
[47]	朱贺, 陈思娇, 宋金丹. 核因子κB及其SUMO化调控与糖尿病肺改变[J]. 医学综述,2012,18(8):1143−1146. [ZHU H, CHEN S J, SONG J D. Nuclear factor κB and its SUMOylation regulation and diabetic lung changes[J]. Medicine Review,2012,18(8):1143−1146. doi: 10.3969/j.issn.1006-2084.2012.08.008
[48]	KULMS D, SCHWARZ T. NF-kappa B and cytokines[J]. Vitam Horm,2006,74:283−300.
[49]	马晓燕, 司英奎, 韩雪霖. 脂肪性肝病中NF-κB活性变化及其意义[J]. 中国病理生理杂志,2007,23(11):2276−2277. [MA X Y, SI Y K, HAN X L. Changes of NF-κB activity in fatty liver disease and its significance[J]. Chinese J Pathophysiology,2007,23(11):2276−2277. doi: 10.3321/j.issn:1000-4718.2007.11.046
[50]	赵彩彦. 实验性脂肪肝病发病机制的研究[D]. 石家庄: 河北医科大学, 2004. ZHAO C Y. Study on the pathogenesis of experimental fatty liver disease[D]. Shijiazhuang: Hebei Medical University, 2004.
[51]	宋艳芳, 林青, 祝先进, 等. 趋化因子CX3CL1对β-淀粉样蛋白激活的小胶质细胞IL-1β、TNF-α和NO表达的影响[J]. 免疫学杂志,2016,32(12):1101−1104. [SONG Y F, LIN Q, ZHU X J, et al. Effect of chemokine CX3CL1 on the expression of IL-1β, TNF-α and NO in microglia activated by β-amyloid[J]. J Immunology,2016,32(12):1101−1104.
[52]	MATTHAY M A, ZIMMERMAN G A. Acute lung injury and the acute respiratorydistress syndrome: Four decades of inquiry into pathogenesis and rational management[J]. American Journal of Respiratory Cell and Molecular Biology,2005,33(4):319−27. doi: 10.1165/rcmb.F305
[53]	王红嫚, 王阳, 薛关生, 等. PDTC对大鼠急性肺损伤 TNF-α、IL-1β及核因子-KB蛋白表达的影响[J]. 中国老年学杂志,2013,33(10):3116−3118. [WANG H M, WANG Y, XUE G S, et al. Effect of PDTC on the expression of TNF-α, IL-1β and nuclear factor-KB protein in rats with acute lung injury[J]. Chinese Journal Gerontology,2013,33(10):3116−3118.
[54]	BAI J, WANG S. Panaxatriol saponin ameliorated liver injury by acetaminophen via restoring thioredoxin-1 and pro-caspase-12[J]. Liver International,2014,34(6):963. doi: 10.1111/liv.12463
[55]	OZ H S, CHEN T S. Green-tea polyphenols downregulate cyclooxygenase and Bcl-2 activity in acetaminophen-induced hepatotoxicity[J]. Digestive Diseases and Sciences,2008,53(11):2980−2988. doi: 10.1007/s10620-008-0239-5

Supplements (0)

Cited By

Cited by

Periodical cited type(18)

1.	周水清，周政. 在饲粮中添加艾草粉对散养鸡的生产性能和抗病能力的影响. 青海畜牧兽医杂志. 2025(01): 13-15+35 .
2.	雷娇，邵起菊，肖欣，李志荣，洪金伶，王森，陈荣祥. 基于HPLC-ECD测定鱼腥草叶多酚含量及抗氧化活性. 食品工业科技. 2024(04): 221-228 . 本站查看
3.	孙立秋，王丹，赵英楠，时志春，李军，王金兰，赵明，张树军. 一测多评法测定艾叶中7个黄酮类成分的含量. 药物分析杂志. 2024(05): 806-815 .
4.	郑文涛，刘元会，魏光强，赵兴文，黄艾祥. 蜂蜜桑茶复合饮料的工艺优化及其抗氧化活性研究. 食品科技. 2024(04): 100-107 .
5.	崔英才，蒋梦宇，刘梦茹，来金良，姚型文，王正国，燕磊，刘永学. 艾草粉对蛋鸡生产性能、蛋品质、抗氧化功能及粪便评分的影响. 饲料研究. 2024(12): 39-43 .
6.	纪德佳，苏慧，刘少雄，廖小兰，侯春久. 黎川县艾叶不同采收期总黄酮及山奈酚、异泽兰黄素的测定. 山东化工. 2024(24): 118-120+124 .
7.	王文哲，梁芳，类成通，孔祥青，王裕玉. 艾蒿及其提取物在动物生产中的应用研究进展. 饲料研究. 2024(24): 158-162 .
8.	廖富友，姚炳浓，杨娇一，王姣，祝保国，杨胜林. 饲粮添加艾叶粉对青年期蛋鸭生长性能、抗氧化功能及免疫性能的影响. 中国家禽. 2023(01): 76-81 .
9.	李胜有，荣冬芸，潘卫东，郑志昌. 艾叶的活性成分、功效及其在动物饲养中的应用研究进展. 饲料研究. 2023(01): 137-141 .
10.	程银水，张勇，秦志旺，董阳，李志浩，郝新才. 超高效液相色谱指纹图谱结合化学模式识别分析艾叶质量. 理化检验-化学分册. 2023(07): 837-843 .
11.	孙君燕，孙敏，宋诗清，王化田，冯涛，姚凌云，俞文华. 香榧纯露的挥发性成分及抗氧化活性研究. 食品工业科技. 2022(03): 40-47 . 本站查看
12.	周永强，赵春丽，殷鑫，周涛，韩伟，张永萍. 小花清风藤醇提物的化学成分及体外抗氧化活性研究. 中国药房. 2022(05): 530-534 .
13.	陈誉华，马钱波，魏元浩，黄倩倩. 艾叶不同极性溶剂提取物的抗氧化能力的研究. 饲料研究. 2022(14): 64-68 .
14.	赵永恒，张勇，秦志旺，董阳，汤哲伟，陈富超，罗雪，郝新才. 气相色谱-质谱指纹图谱结合化学计量学方法分析不同产地艾叶挥发油的差异. 理化检验-化学分册. 2022(11): 1277-1282 .
15.	朱平平，覃智恒，彭慧倩，刘育文，刘静，陈锦涛，彭颖. 艾叶中多糖和黄酮联合提取工艺及抗氧化性研究. 广州化工. 2022(23): 66-69+98 .
16.	王美英，李化强，吴菲菲. 超声波辅助提取竹叶鸡爪茶总黄酮的工艺优化及抗氧化、抑菌活性研究. 粮食与油脂. 2021(06): 105-111 .
17.	王举翠，李明芝. 鲜芦根荷叶复合饮料研制及对运动耐力的影响研究. 食品安全质量检测学报. 2021(17): 7021-7029 .
18.	梅瑜，徐世强，顾艳，孙铭阳，周芳，李静宇，张闻婷，王继华. 红脚艾蒿的转录组解析. 广东农业科学. 2021(12): 174-180 .